Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00462735 · OUTCOME

UW-QOLR: Quality of Life Score

Fluorouracil, Hydroxyurea, Cetuximab and Twice-daily Intensity Radiation Therapy for Advanced Head and Neck Cancer · Source last updated 2018-03-13

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
MEAN
Unit
units on a scale
Interval / dispersion
Full Range
Time frame
2 years

What was measured

University of Washington Quality of Life (UW-QOLR) questionnaire - covers 12 domains - pain, appearance, activity, recreation, swallowing, chewing, speech, shoulder function, taste, saliva, mood and anxiety. Each domain have between 3 and 6 response options that are scaled evenly from 0 (worst) to 100 (best) according to the hierarchy of response and reported as one composite score from 0 (worst) to 100 (best).

Analysis population: Twenty patients completed the UW-QOLR questionnaire before and after therapy.

Groups in this outcome

Advanced Head and Neck Cancer

Cetuximab - 250 mg/m2 on Day 1 after the first dose of radiation was administered to all patients. Hydroxyurea - 500 mg orally every 12 hours with the morning dose administered 2 hours before radiation. Fluorouracil - continuous-infusion 5-FU at a dose of 600 mg/m2 daily for 120 hours. Radiotherapy.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Advanced Head and Neck Cancer20

Reported measurements

Source class 1
Values in units on a scale · Interval/dispersion: Full Range
GroupValueSpreadLowerUpperComment
Advanced Head and Neck Cancer80Not reported0100Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        0
        upper Limit
        100
        value
        80
denoms
  1. counts
    1. group Id
      OG000
      value
      20
    units
    Participants
description
University of Washington Quality of Life (UW-QOLR) questionnaire - covers 12 domains - pain, appearance, activity, recreation, swallowing, chewing, speech, shoulder function, taste, saliva, mood and anxiety. Each domain have between 3 and 6 response options that are scaled evenly from 0 (worst) to 100 (best) according to the hierarchy of response and reported as one composite score from 0 (worst) to 100 (best).
dispersion Type
Full Range
groups
  1. description
    Cetuximab - 250 mg/m2 on Day 1 after the first dose of radiation was administered to all patients. Hydroxyurea - 500 mg orally every 12 hours with the morning dose administered 2 hours before radiation. Fluorouracil - continuous-infusion 5-FU at a dose of 600 mg/m2 daily for 120 hours. Radiotherapy.
    id
    OG000
    title
    Advanced Head and Neck Cancer
param Type
MEAN
population Description
Twenty patients completed the UW-QOLR questionnaire before and after therapy.
reporting Status
POSTED
time Frame
2 years
title
UW-QOLR: Quality of Life Score
type
SECONDARY
unit Of Measure
units on a scale

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice